GfK drops TNS bid

Share this article:

A proposed acquisition of TNS by GfK was canceled, according to an article published in Daily Research News Online.

An original “merger of equals” between the two market research firms was announced last April. According to the Daily Research News Online article, the merger was thwarted by a WPP bid of $2.1 billion to acquire TNS, which was preliminarily rejected on the grounds that it “substantially undervalued” the company.

According to a GfK company statement, the management board "has concluded that the terms of the financing available did not enable a sufficiently compelling alternative cash offer to be made for TNS that was also economically in the best interests of the GfK shareholders."

Marion Eisenblatter, a GfK spokesperson, said the company will continue looking for aquisitions in the future, but probably won't consider firms as large as TNS.

GfK is a market research firm employing approximately 9,300 people worldwide. The initial merger of equals with TNS would have created GfK-TNS, with global head offices in London and Germany.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.

Five things for Pharma Marketers to Know: Thursday, August 28

Five things for Pharma Marketers to Know: Thursday, ...

Human testing of GSK's Ebola virus starts next week, menopause is a costly healthcare concern, and a small conversation with pharmacists may have a big impact.